Ensuring safer opioid systems

0
Opioid analgesic stewardship is now a national medicines safety priority, targeting preventable harm across acute settings and transitions to community care.

Systemic corticosteroids for dyspnoea

0
The effectiveness of systemic corticosteroids for the management of dyspnoea in adults with advanced cancer. Dyspnoea affects almost 70% of advanced cancer patients at the...

2019 year in review

0
It was a big year for Australian pharmacists, with the release of important reports calling for reform for the profession and providing a vision...

Tips for extended telehealth consultations for medicines reviews

0
In response to the COVID-19 pandemic, pharmacists may continue delivering medicine reviews via telehealth until 31 March 2021.

How to get the most out of your PSA21 Virtual experience

0
There are just two days until PSA21 Virtual begins, with an exciting program of clinical, therapeutic and industry sessions for pharmacists in all practice settings.

TGA changes continue to impact and sometimes baffle pharmacists

0
A number of recent decisions by the Therapeutic Goods Administration (TGA) are highly relevant to pharmacists in Australia. Firstly, the interim decision from the...